PARK2andPACRGare commonly downregulated in clear-cell renal cell carcinoma and are associated with aggressive disease and poor clinical outcome

2012 ◽  
Vol 52 (3) ◽  
pp. 265-273 ◽  
Author(s):  
Marieta I. Toma ◽  
Daniela Wuttig ◽  
Sandy Kaiser ◽  
Alexander Herr ◽  
Thomas Weber ◽  
...  
Oncotarget ◽  
2017 ◽  
Vol 8 (55) ◽  
pp. 94819-94833 ◽  
Author(s):  
Wen Xiao ◽  
Zhiyong Xiong ◽  
Changfei Yuan ◽  
Lin Bao ◽  
Di Liu ◽  
...  

EBioMedicine ◽  
2017 ◽  
Vol 15 ◽  
pp. 62-72 ◽  
Author(s):  
Junfang Zheng ◽  
Lei Wang ◽  
Zhiqiang Peng ◽  
Ying Yang ◽  
Duiping Feng ◽  
...  

2015 ◽  
Vol 37 (8) ◽  
pp. e75-e76 ◽  
Author(s):  
P. Fisel ◽  
V. Stühler ◽  
S. Winter ◽  
S. Rausch ◽  
J. Hennenlotter ◽  
...  

2014 ◽  
Vol 42 (2) ◽  
pp. 282-291 ◽  
Author(s):  
Qianfeng Zhuang ◽  
Xi Qian ◽  
Yunjie Cao ◽  
Min Fan ◽  
Xianlin Xu ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document